deflazacort has been researched along with Heart Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giannakopoulou, A; Karanasios, E; Kolovou, G; Markousis-Mavrogenis, G; Mavrogeni, S; Noutsias, M; Papadopoulos, G; Papavasiliou, A; Pons, R | 1 |
Agüero, J; Almenar Bonet, L; Martínez-Dolz, L; Moro, JA; Raso, R; Salvador, A; Sánchez-Lázaro, I | 1 |
1 trial(s) available for deflazacort and Heart Diseases
Article | Year |
---|---|
Randomized prospective study of the evolution of renal function depending on the anticalcineurin used.
Topics: Aged; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Mycophenolic Acid; Pregnenediones; Tacrolimus | 2008 |
1 other study(ies) available for deflazacort and Heart Diseases
Article | Year |
---|---|
Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Asymptomatic Diseases; Case-Control Studies; Child; Contrast Media; Cross-Sectional Studies; Echocardiography; Electrocardiography; Gadolinium DTPA; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Perindopril; Pregnenediones; Protective Agents; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Function, Right | 2017 |